Schering-Plough taps MediaVest for US media

Share this article:

Schering-Plough awarded media duties in the US to Publicis Groupe's MediaVest, following a review. 

The move, first reported by Advertising Age, will include Levitra and Nasonex, an erectile dysfunction drug and a nasal spray, respectively. 

Omnicom Group's OMD previously handled some of the media duties for Schering-Plough.

Share this article:

Email Newsletters

More in News

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi tightens PCSK9 race, exceeds Q2 expectations

Sanofi and partner Regeneron attached a $67.5-million priority review voucher to their experimental cholesterol drug alirocumab, making for a tighter race with Amgen.

HHS shows how diabetes adds up

HHS shows how diabetes adds up

A 2005-to-2010 survey shows diabetics 65-and-up juggle at least four co-morbid conditions and five medications for them.

AstraZeneca beefs up respiratory portfolio

AstraZeneca beefs up respiratory portfolio

AstraZeneca has made an $875-million move to beef up its respiratory pipeline by making Almirall's lineup its own.